USD 1001.59 Million
MicroRNA Market Size, Share, Growth Analysis, By Products & Services(Services [Type (Isolation & Purification, miRNA cDNA Synthesis, Profiling, Localization), By Application(Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease), By End-use(Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2216 |
Region:
Global |
Published Date: September, 2024
Pages:
157
|Tables:
61
|Figures:
75
MicroRNA Market Insights
MicroRNA Market size was valued at USD 1.20 billion in 2022 and is poised to grow from USD 1.35 billion in 2023 to USD 3.58 billion by 2031, growing at a CAGR of 12.90% during the forecast period (2024-2031).
According to the estimates from the American Cancer Society, 609,360 deaths from cancer were registered in 2022 alone in the US, and over 1.9 million people were newly diagnosed with cancer. In addition, the pace at which microRNA diagnostics gained ground in clinical settings brought forward developments in precision medicine of cancer. As per the microRNA market analysis, the two key factors driving the growth of the market include growing prevalence of such diseases as cancer, heart disease, and other neurological conditions worldwide and rapid developments in genomic technologies. Furthermore, besides this, miRNAs have offered excellent noninvasive biomarkers for cancer. The reason behind this is that various secretions from numerous cells are present in various bodily fluids. Consequently, the functions of microRNA in gene regulation and disease pathways create a considerable market demand that drives the microRNA market growth forward.
Since miRNAs play a crucial role in the post-transcriptional regulation of gene expression, they are rapidly being recognized as robust biomarkers of human disorders. Support for their utility as diagnostic and prognostic biomarkers in the form of blood is seen through their stability within serum and plasma. In addition, circulating miRNAs inside exosomes are serum biomarkers used to elucidate information regarding the immunological status in both healthy and pathological states. For instance, the concentration of microRNA-150 in the blood after lymphocyte activation sharply increases in vaccinated subjects. That lends credibility to the use of circulating microRNAs as potential indicators of immunologic status. Consequently, and expanding the business in general, prospects of using microRNA as a biomarker for a variety of diseases have an argument on its side.
US MicroRNA Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Product
Fastest Growth
Product
Growth Rate
17.2% CAGR
Global MicroRNA Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
MicroRNA Market Segmental Analysis
Global MicroRNA Market is segmented by Products & Services, Application, End-use, and region. Based on Products & Services, the market is segmented into services, and products. Based on Application, the market is segmented into Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, and Others. Based on End-use, the market is segmented into Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
MicroRNA Market Analysis by Application
Primarily because of the rapidly expanding number of cases of some chronic diseases across the globe, in 2023, the disease diagnostics segment had the largest share of the market. With higher percentages of people affected by diseases such as diabetes, heart conditions, and cancers due to ecological factors and lifestyle changes, the need for precise and on-time diagnostic solutions is rising. The advanced molecular diagnostics that offer a more sensitive and specific diagnostic require early diseases and relevant planning for the therapy to be administered. Advances in testing technologies provide capacity for timely clinical choices thus making the segment more appealing toward the growing requirement for sophisticated diagnostic tools.
However, the isolation & purification segment is anticipated to grow significantly during the projection period. Major growth factors for the segment in terms of significant expansion possibilities during the forecast period are based on recent years' growing number of kits introduced for isolation and purification. Kits are available for different purposes, that is, as clinical diagnostics, research, and biopharmaceuticals production. This increasing demand for accurate and reliable results in both laboratory and clinical settings shows up as a growing demand for high-quality reagents along with effective isolation techniques. Improvements in the technology and methodology of these kits are also making them more accessible to researchers and medical professionals, which is also affecting their application. Accordingly, this market is predicted to have growth at a very fast pace due to innovation coupled with increased acceptance across a range of industries.
MicroRNA Market Analysis by End User
According to the microRNA market analysis, in 2023, pharma & biotech companies led this market. These firms are leaders in collaborative agreements and university partnerships that allow them to tap into cutting-edge research and collaborate on groundbreaking projects that will accelerate the pace of developments associated with microRNA. For instance, Singapore-based biotech company MiRXES recently boasted several new capabilities in August 2022. It did so by declaring an Industry 4.0 production facility, two more labs, and a joint multi-cancer screening research initiative. The idea is according to MiRXES's objective of developing improved manufacturing and research capabilities focused on developing miRNA-based diagnostics in the detection of diseases.
The academic & research institutes segment is expected to increase profitably over the forecasted period. Most of the current ongoing work in academia and research institutes utilize miRNA technologies and associated products. Moreover, further research studies are expected to raise the growth rate of the market. For instance, in October 2022, BHU Institute of Science researchers at Varanasi School of Biotechnology isolated a microRNA that selectively kills cervical cancer cells. Further research on the study may eventually be used for the development of a safe therapy called micro-RNA therapy for cervical cancer.
Global MicroRNA Market By Research tool
To get detailed analysis on other segments, Request For Free Sample Report
MicroRNA Market Regional Insights
The microRNA market outlook highlighted that in 2023, the market was dominated by North America. This is so because growth in the region of microRNA is attributed to a number of factors, such as availability of significant population of major players in the area; some of which are Merck KGaA., NanoString Technologies, Inc., and Thermo Fisher Scientific, besides others whose expenditure on R&D has increased with them trying to come up with more advanced and innovative products. In 2023, the US accounted for the highest market share in North America. Some of the prominent players of the market with headquarters based in the US are Thermo Fisher Scientific, Merck KGaA., and QIAGEN. Distribution networks form the backbone of these players. The country enjoys simple access to miRNA services and products.
Asia-Pacific will be growing at the fastest rate over the projection period. Key players in the region will be energized by growth opportunities due to factors such as the presence of a humongous target population, faster uptake of a range of technologies, presence of a multitude of start-ups along with an emergent healthcare infrastructure, and high unmet clinical needs. In 2023, the country, China, within Asia-Pacific accounted for the largest microRNA market share. The growing importance of precision medicine and the huge potential of miRNAs in this regard are anticipated to drive the microRNA industry growth forward.
Global MicroRNA Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
MicroRNA Market Dynamics
MicroRNA Market Drivers
Increased Public and Corporate Funding in Genomic Research
- Public and corporate funding in genomic research is opening new benefits in the microRNA industry. There is increased funding for conducting research in how microRNAs regulate gene functions and the development of illness. Such funding fast-tracks the creation of diagnostics and treatments through microRNA bases, and it facilitates innovation and cooperative research projects, thereby establishing their use in clinical settings.
Enhanced Understanding and Application of Biomarkers
- MicroRNAs are gaining more importance as non-invasive biomarkers, and the medical profession and scientists are slowly realizing that biomarkers hold the key to the early detection and monitoring of disease conditions. MicroRNAs, being stable in body fluids, represent an ideal solution for diagnostic purposes and a representation of diseased condition. Growing awareness is thereby driving the demand for microRNA-based assays that will help to provide critical information regarding disease conditions and responses to treatment.
MicroRNA Market Restraints
Complex microRNA Biology
- MicroRNA biology is also complex, partly because it involves mode of action, mode of interaction with other biological components, and variability from different tissues. This complexity may delay pinpoint identification of specific treatment targets and translate scientific findings into practice somewhat harder, thus threatening the growth of the microRNA market.
Market Fragmentation
- This fragmentation of the microRNA industry, with many companies driving in different directions to research, diagnose, and treat microRNA, will make it difficult for end consumers to make the best choices, which again leads to inconsistencies in the quality and reliability of products. It may further complicate the formation of standardized microRNA applications in the clinical environment and problematize working teams.
Request Free Customization of this report to help us to meet your business objectives.
MicroRNA Market Competitive Landscape
The global microRNA industry is characterized by several competitors who are escalating their fight to capture market shares and gain a competitive edge. Research and development activities aimed at discovering new microRNA biomarkers, therapeutic targets, and diagnostic tools are driving the industry. Therefore, rivalry among market players is escalating too since such discoveries are promoting the development of new products and services based on microRNAs. Major players in the microRNA market include contract research firms, government and university research facilities, and biotechnology and pharmaceutical corporations. These organizations maintain the market via in-depth research, clinical studies, and commercialization of microRNA-based products.
MicroRNA Market Top Player’s Company Profile
- Thermo Fisher Scientific, Inc. (US)
- QIAGEN (Germany)
- NanoString Technologies, Inc. (US)
- Merck KGaA (Germany)
- Takara Bio, Inc. (Japan)
- BioGenex (US)
- GeneCopoeia, Inc. (US)
- New England Biolabs (US)
- Agilent Technologies, Inc. (US)
- Illumina, Inc. (US)
- Abcam plc (UK)
- Roche Holding AG (Switzerland)
- Arcturus Therapeutics Ltd. (US)
- Synthego Corporation (US)
- Bio-Techne Corporation (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Asuragen, Inc. (US)
- Cell Signaling Technology, Inc. (US)
- Molecular Cloud (China)
- Ribomed Biotechnologies, Inc. (US)
- Sirnaomics Inc. (US)
MicroRNA Market Recent Developments
- Thermo Fisher Scientific plans to spend USD 3.1 billion for October 2023 acquisition of Olink Holding AB towards expanding the portfolio of life sciences offerings supporting drug discovery.
- With an investigation of microRNAs (miRNAs), the group of scientists at the University of Illinois Urbana was able to develop a new point-of-care cancer diagnosis test with high success rate in February 2022. A recently developed assay "makes use of nanoparticles that capture tumor-specific miRNAs from human serum, offering an efficient method for potentially providing an attractive strategy for rapid and accurate cancer screening at the point of service.".
- Biotechnology firm MiRXES has just unveiled multiple innovation upgrades that it hopes will bolster its research and manufacturing capacity on the miRNA-based testing for illness detection. Among these innovations is the launch of a cooperative multi-cancer screening research project, building of an Industry 4.0 (i4.0) production facility and installment of two cutting-edge labs. The recent launches were announced by MiRXES, a company based in Singapore, late in August 2022.
MicroRNA Key Market Trends
- Development of Combination Therapies: Major microRNA market trends include combination therapies. There is a growing trend wherein more emphasis is being laid down on combination therapy that consists of using a classical treatment in combination with a microRNA-based treatment. Researchers are looking into how they can better improve treatment outcomes and surmount drug resistance through the potential use of microRNAs in interfering with a multiplicity of pathways or enhancing the effectiveness of drugs already available on the market. As such, the trend tends to be more holistic where instead of targeting one pathway, the drugs and therapeutic approaches manage to achieve therapeutic gain through the exploitation of unique properties of microRNAs.
- Integration of Bioinformatics and AI: Tools in bioinformatics are currently being combined with artificial intelligence and applied in the studies of microRNA. Such a combination has been identified as helping researchers gain clear insight into the potential targets of microRNAs, considerable analysis of large datasets, prediction of functional functions, and priority roles toward devising novel therapeutic approaches and determining new disease biomarkers. Emerging computational techniques have enhanced the understanding of microRNA networks and interactions and have also provided several newfound targets and biomarkers of disease.
MicroRNA Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, due to the growing prevalence of chronic diseases, advances in molecular biological methods, and higher funding for genomic research, the microRNA industry is predicted to boom in the near future. It can be highlighted that microRNAs hold a great importance to personalized medicine since they may function as potential biomarkers and therapeutic targets. However, product development may encounter issues with prohibitively high development costs, overly complex regulations, and the complexity of biology linked to microRNAs. New trends, such as the development of combination drugs and collaborative research partnerships, offer great opportunities for innovation. To fully realize the promise of microRNA applications in healthcare it will be important to concentrate on making existing obstacles disappear through technical developments as industry develops.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.20 billion |
| Market size value in 2031 | USD 3.58 billion |
| Growth Rate | 12.90% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on MicroRNA Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on MicroRNA Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the MicroRNA Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the MicroRNA Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the MicroRNA Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the MicroRNA Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
